| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (Right to Buy) | 40k | $5.52 | $220.8k | | 06/06/2023 |
| 05/17/2023 | aTYR PHARMA INC | LIFE | Gift | Common Stock | 6k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | aTYR PHARMA INC | LIFE | Gift | Common Stock | 6k | $0.00 | $0 | See Footnote | 05/17/2023 |
| 05/17/2023 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 12k | $2.52 | $30.2k | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 13.5k | $17.11 | $231k | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 4.5k | $0.00 | $0 | | 05/17/2023 |
| 04/26/2023 | aTYR PHARMA INC | LIFE | Exercise | Restricted Stock Unit | 6k | $0.00 | $0 | | 04/26/2023 |
| 06/09/2022 | FATE THERAPEUTICS INC | FATE | Grant | | 8.6k | $0.00 | $0 | | 06/09/2022 |
| 06/09/2022 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (Right to Buy) | 11.9k | $23.48 | $279.2k | | 06/09/2022 |
| 06/03/2022 | FATE THERAPEUTICS INC | FATE | Sale | Common Stock | 1.4k | $22.81 | $32.8k | | 06/03/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $21.38 | $192.4k | | 05/11/2022 |
| 04/26/2022 | aTYR PHARMA INC | LIFE | Grant | Restricted Stock Units | 6k | $0.00 | $0 | | 04/26/2022 |
| 06/02/2021 | FATE THERAPEUTICS INC | FATE | Grant | | 2.7k | $0.00 | $0 | | 06/02/2021 |
| 06/02/2021 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (Right to Buy) | 4.3k | $68.94 | $298.8k | | 06/02/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $18.27 | $164.4k | | 05/14/2021 |
| 04/28/2021 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 1.4k | $4.21 | $6k | | 04/28/2021 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 9k | $15.43 | $138.9k | | 05/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3k | $0.00 | $0 | | 05/15/2020 |
| 05/06/2020 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 1.4k | $3.65 | $5.2k | | 05/06/2020 |
| 05/01/2020 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (right to buy) | 16k | $26.59 | $425.4k | | 05/01/2020 |
| 05/08/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 8k | $17.94 | $143.5k | | 05/08/2019 |
| 05/08/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 2k | $0.00 | $0 | | 05/08/2019 |
| 05/08/2019 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 20k | $0.58 | $11.7k | | 05/08/2019 |
| 05/03/2019 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (right to buy) | 16k | $17.15 | $274.4k | | 05/03/2019 |
| 05/15/2018 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 20k | $1.35 | $27k | | 05/15/2018 |
| 05/09/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Employee Stock Option (Right to Buy) | 10k | $26.52 | $265.2k | | 05/09/2018 |
| 05/09/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 05/09/2018 |
| 05/02/2018 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (right to buy) | 16k | $9.78 | $156.5k | | 05/02/2018 |
| 05/09/2017 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 20k | $3.15 | $63k | | 05/09/2017 |
| 05/02/2017 | FATE THERAPEUTICS INC | FATE | Grant | Stock Option (right to buy) | 25k | $4.73 | $118.2k | | 05/02/2017 |
| 04/07/2017 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 32k | $3.25 | $104k | | 04/07/2017 |
| 02/03/2017 | NEUROCRINE BIOSCIENCES INC | NBIX | Sale | Common Stock | 1.5k | $42.55 | $63.8k | | 02/03/2017 |
| 11/23/2016 | FATE THERAPEUTICS INC | FATE | Purchase | Common Stock | 56.4k | $2.66 | $150k | | 11/23/2016 |
|